Sanofi reported EUR2.63B in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
AbbVie USD 3.84B 205M Sep/2026
Amgen USD 1.68B 40M Sep/2026
AstraZeneca USD 4.07B 1.73B Sep/2026
Bristol-Myers Squibb USD 1.7B 127M Sep/2026
Canopy Growth CAD 33.99M 2.83M Jun/2026
Corcept Therapeutics USD 142.04M 14.86M Sep/2026
Drreddys Laboratories INR 28.08B 13.61B Sep/2026
Eli Lilly USD 3.12B 305M Sep/2026
Genmab DKK 205M 39M Jun/2026
GlaxoSmithKline GBP 2.16B 39M Sep/2026
Glaxosmithkline GBP 2.38B 264M Sep/2026
J&J USD 6.25B 168M Sep/2026
Lakefront Biotherapeutics EUR 22.5M 13M Jun/2026
Merck USD 2.86B 25M Sep/2026
Novartis USD 3.08B 163M Sep/2026
Novartis USD 3.08B 58M Sep/2026
Pacira USD 950.8M 858.99M Sep/2026
Perrigo USD 271.7M 3.01B Sep/2026
Pfizer USD 3.28B 132M Sep/2026
Phibro Animal Health USD 78.32M 10.24M Dec/2025
Prestige Brands USD 2.08B 2.04B Sep/2026
Roche Holding CHF 6.37B 908M Jun/2026
Sanofi EUR 2.31B 325M Sep/2026
Sanofi EUR 2.63B 140M Jun/2026
Supernus Pharmaceuticals USD 133.64M 15.41M Jun/2026
UCB EUR 1.47B 193M Dec/2025
Zoetis USD 582M 10M Sep/2026